Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Major Biotechs Send Short Sellers Running for Cover

The short interest data are out for the most recent settlement date, July 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

After a wretched 2016, when many of the top biotech companies were hit hard by campaign rhetoric, the industry has roared back to life this year. While nowhere near the ...
Read Full Story »

Short Sellers Run for Cover From Major Biotech Stocks

The short interest data are out for the most recent settlement date, July 14. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, June 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotech Short Interest Surges

The short interest data are out for the most recent settlement date, June 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Most of the large biotech outfits in America have gone into a limbo mode. Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) fits that bill despite having a $26.5 billion market cap. Is ...
Read Full Story »

Wednesday’s Biggest Winners and Losers in the S&P 500

June 14, 2017: The S&P 500 closed lower, down 0.1% at 2,437.90. The DJIA closed up 0.2% at 21,376.47. Separately, the Nasdaq closed lower 0.4% at 6,194.89. Wednesday saw a mixed ...
Read Full Story »

Alexion Pharmaceuticals Adds New CFO From Biogen

Shares of Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) saw a handy gain early on Wednesday after the company announced that there would be changes in its leadership. The company announced that ...
Read Full Story »

Short Interest Surges in Major Biotechs

The short interest data are out for the most recent settlement date, May 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

4 Top Analyst Stock Picks Predicted to Rise 50% to 100%

The bull market is eight years old and investors have bought every major pullback for years. Friday, June 9, 2017, reminded the tech investors that Wall Street's favorite (and most ...
Read Full Story »

Avon, Fitbit Plunge into Friday’s 52-Week Low Club

May 26, 2017: Here are four stocks trading with relatively heavy volume among 111 equities making new 52-week lows in Friday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »

Short Sellers Raise the Stakes in Major Biotechs

The short interest data are out for the most recent settlement date, May 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Akamai, Alexion, Altria, Chipotle, MEI Pharma, Netflix, PayPal and More

Stocks were indicated to open higher again on Thursday, and the S&P is indicated to be above 2,400 and the Dow is to be above 21,000. The bull market is ...
Read Full Story »

Chico’s FAS, Southwestern Energy Drop into Wednesday’s 52-Week Low Club

May 24, 2017: Here are four stocks trading with relatively heavy volume among 106 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »

Alexion, Teva Plunge into Tuesday’s 52-Week Low Club

May 23, 2017: Here are four stocks trading with relatively heavy volume among 88 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »